| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | EP0789761B1 Human scf, a splice variant thereof, its pharmaceutical use |
| 07/20/2005 | EP0759939B1 Methods and compositions for the dry powder formulation of interferons |
| 07/20/2005 | EP0759075B1 Apoptosis regulating gene |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | EP0624095B2 Methods and compositions for reducing blood loss |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1643159A Method for generating primate trophoblasts |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643143A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/20/2005 | CN1643140A Combination of a growth factor and a protease enzyme |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643130A A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642979A VEGF peptides and their use |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642975A Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| 07/20/2005 | CN1642974A Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C) |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642968A A human ribonucleotide reductase M2 subunit |
| 07/20/2005 | CN1642967A Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 07/20/2005 | CN1642951A Heterocyclic tripeptides as hepatitis c inhibitors |
| 07/20/2005 | CN1642947A Crystalline forms of (2S)-N-5[amino(imino)methyl]-2-thienylmethyl-1-(2R)-2[(carboxymethyl) amino]-3, 3-diphenylpropanoyl-2-pyrrolidinecarboxamide nHO |
| 07/20/2005 | CN1642946A Maleic acid salt of(2s)-N-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2R)-2-[(carboxymethyl)amino]-3, 3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing same |
| 07/20/2005 | CN1642579A Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| 07/20/2005 | CN1642570A Stable pharmaceutical composition containing factor viii |
| 07/20/2005 | CN1642569A Treatment of type I diabetes |
| 07/20/2005 | CN1642568A Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642545A Time-resolved fluorescence assay for the detection of multimeric forms ofA-beta(beta) or other aggregating polypeptides |
| 07/20/2005 | CN1642496A Enzyme disruption of bacterial biofilms |
| 07/20/2005 | CN1641033A Novel marneffei penicillium TIM9 protein and its coding sequence |
| 07/20/2005 | CN1641032A Novel marneffei penicillium ERG25 Gene and its coding protein |
| 07/20/2005 | CN1641031A Novel marneffei penicillium TIM17 protein and its coding sequence |
| 07/20/2005 | CN1641024A Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 07/20/2005 | CN1641021A NDRG2 and NDRG4 protein and their use for diagnosing and suppressing tumour |
| 07/20/2005 | CN1640891A Epinephelus anti-transgenosis protein and nucleotide sequence and use thereof |
| 07/20/2005 | CN1640890A Cell withering factor derivated from placents |
| 07/20/2005 | CN1640887A 'Heat shock protein special extraction kit' for biological therapy |
| 07/20/2005 | CN1640491A Recombinant human epidermal growth factor compound biological agent and its use |
| 07/20/2005 | CN1640490A Urine polyacid peptide composition and its use |
| 07/20/2005 | CN1640489A Method for preparing urine polyacid peptide composition |
| 07/20/2005 | CN1640381A Lipsotrichia-stopping hair-growing preparation |
| 07/20/2005 | CN1211492C Method for preparing easy body absorption protein-calcium by enzyme and health food produced by said protein-calcium |
| 07/20/2005 | CN1211488C Modified plant viruses as vectors of heterologous peptides |
| 07/20/2005 | CN1211487C Mutants of streptococcal toxin A and methods of use |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211402C Novel use of mouse leukocyte interleukin-17 receptor sample protein |
| 07/20/2005 | CN1211401C Human leukocyte interleukin-17 receptor sample protein, and coding gene and use thereof |
| 07/20/2005 | CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/20/2005 | CN1211120C Injection for treating hydrocele of testis |
| 07/20/2005 | CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same |
| 07/20/2005 | CN1211080C Method for preparing microcapsule |
| 07/20/2005 | CN1211070C Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 07/20/2005 | CN1211019C Compsns. contg. peptide and electrolyte excretion promoter and foods contg. same |
| 07/19/2005 | US6919439 Derivatized oligonucleotides having improved uptake and other properties |
| 07/19/2005 | US6919438 Comprises viral expression vector coding envelope protein domains for use as gene therapeutic tool in the treatment of autoimmune diseases |
| 07/19/2005 | US6919433 Antibodies to protein HPMBQ91 |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919431 Comprises soluble n-ethylmaleimide sensitive fusion protein attachment proteins (SNAPS) for treatment and prevention of tumors, blood, viral autoimmune and inflammatory diseases |
| 07/19/2005 | US6919430 Comprises beta-galactoside-binding lectin for treatment and prevention of tumors, blood, viral autoimmune and inflammatory diseases |
| 07/19/2005 | US6919427 Mimetic protein for modulating protein binding activity and treatment and prevention of cancer, blood, viral, inflammatory and autoimmune diseases |
| 07/19/2005 | US6919426 Peptides and related molecules that modulate nerve growth factor activity |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919423 A 2-thiazole-4-(pyrrole-3yl)-oxo-7-methoxyquinoline derivatives, a protease enzyme inhibitors, for treating viral disease |
| 07/19/2005 | US6919380 Carbocyclic esters such as 5-chloro-2-methanesulfonylindan-1--yl-4-chlorobenzoate, used as anorexigenic agents; dietetics |
| 07/19/2005 | US6919374 Viscosity modulating substance and use thereof |
| 07/19/2005 | US6919321 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 07/19/2005 | US6919318 Enhancing immune responses to genetic immunization by using a chemokine |
| 07/19/2005 | US6919315 Administering a patient an effective amount of a triamide compound to treat the medical disorders resulting from a deficiency in growth hormone |
| 07/19/2005 | US6919312 Polysaccharides |
| 07/19/2005 | US6919311 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII |
| 07/19/2005 | US6919310 Administering drug formulation comprising opioidergic agent and an insulin secretagogue for therapy of human suffering from one or more conditions included within Coronary Heart Disease Risk Factor Syndrome |
| 07/19/2005 | US6919309 Methods and compositions for inhibiting angiogenesis |
| 07/19/2005 | US6919308 Comprising a matrix containing pure natural-sourced mammalian osteogenic protein |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919306 Method of skin care |
| 07/19/2005 | US6919208 Methods and compositions for enhancing the delivery of a nucleic acid to a cell |
| 07/19/2005 | US6919206 Medium containing flt3 ligand for culturing hematophoietic cells |
| 07/19/2005 | US6919196 Parvovirus NS1 variants |
| 07/19/2005 | US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein |
| 07/19/2005 | US6919086 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 07/19/2005 | US6919080 Polypeptide for use in the treatment of respiratory disorders in poultry |
| 07/19/2005 | US6919079 FcεPE chimeric protein for targeted treatment of allergy responses, a method for its production and pharmaceutical compositions containing the same |
| 07/19/2005 | US6919078 Antibodies to human tumor necrosis factor receptor TR9 |
| 07/19/2005 | US6919076 Conjugate of a nonextracellular matrix protein, nonlabeling agent of an anti- nerve gas, neurotoxin and gluacoma agents and a carboxamide- carrying linking molecule that contains >/= 2 linked glutamines and is a substrate of transglutaminase |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | US6919070 Stomatic composition |
| 07/15/2005 | WO2004068143A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp |
| 07/15/2005 | CA2513593A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp |
| 07/14/2005 | WO2005063987A1 Gp153: methods and compositions for treating cancer |
| 07/14/2005 | WO2005063986A1 Immune response regulatory protein |
| 07/14/2005 | WO2005063966A2 Method for in vitro differentiation of neuronal stem cells or cells derived from neuronal stem cells |
| 07/14/2005 | WO2005063965A1 Tissue regeneration method |
| 07/14/2005 | WO2005063820A2 Il-7 fusion proteins |
| 07/14/2005 | WO2005063809A1 Nature-identical erythropoietin |
| 07/14/2005 | WO2005063808A1 Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS |